46 results
DEFA14A
ACXP
Acurx Pharmaceuticals Inc
29 Apr 24
Additional proxy soliciting materials
4:12pm
Materials
Soliciting Material Under Rule 14a-12
ACURX PHARMACEUTICALS, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s … with preliminary materials.
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
Your Vote Counts! *Please
8-K
EX-1.1
ACXP
Acurx Pharmaceuticals Inc
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
, binding upon such acquiror, to acquire such Placement Shares.
(c) Offering Materials Furnished to the Sales Agent. Copies of the Registration … in the Common Stock shall not have been suspended on the Exchange and the Common Stock shall not have been delisted from the Exchange.
(k) Other Materials
8-K
EX-1.1
6eemaxg5
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-10.1
hn1e88hlihwb f7eu67
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
DEFA14A
necg5i
27 Apr 23
Additional proxy soliciting materials
4:14pm
PRE 14A
y1v4o2u6n26qn44c6sh
17 Apr 23
Preliminary proxy
4:05pm
8-K
EX-10.1
2137 c4xq
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
8-K
EX-1.1
0tbaxdx
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
S-3
EX-4.5
nzbdqmho 2vd
1 Jul 22
Shelf registration
8:46am
S-3
EX-4.6
heu2 n0l9zp
1 Jul 22
Shelf registration
8:46am